ADARx Pharmaceuticals Inc.
Develops RNA-targeting therapeutics for treating genetic and cardiometabolic diseases.
biotechpharmaceuticals
Company facts
- Founded
- 2019
- Employees
- 89
- Headquarters
- United States
- Type
- Private
- Funding
- Series C · $200M · 2023